ClinicalTrials.Veeva

Find clinical trials for Pancreatic Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Lung Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Boston, MA, USA:

Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer

and radiation therapy in people with microsatellite stable pancreatic cancer.The names of the study interventions involved in this ...

Active, not recruiting
Metastatic Pancreatic Cancer
Pancreatic Cancer
Drug: Ipilimumab
Drug: Nivolumab

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 2 other locations

This research study is studying an investigational therapy as a possible treatment for pancreatic cancer.The drugs involved in this...

Active, not recruiting
Pancreatic Cancer
Drug: Niraparib

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 2 other locations

receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...

Active, not recruiting
Pancreatic Cancer
Radiation: Stereotactic MRI-guided On-table Adaptive Radiation Therapy
ViewRay

Boston, Massachusetts, United States and 12 other locations

This research is being done to evaluate the safety and effectiveness of the drug NIS793 in combination with the standard of care treatment FOLFIRINOX...

Enrolling
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: Irinotecan
Radiation: Chemoradiation

Phase 1

Colin D. Weekes, M.D.

Boston, Massachusetts, United States

This research study is studying a combination of drugs with radiation therapy as a possible treatment for Microsatellite Stable Colorectal Cancer...

Enrolling
Microsatellite Stable Colorectal Cancer
MSI High Colorectal Cancer
Drug: Nivolumab
Radiation: Radiation Therapy

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States

This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions involved in th...

Active, not recruiting
Pancreatic Cancer
Drug: Nivolumab
Drug: FOLFIRINOX

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 9 other locations

gemcitabine and nab-paclitaxel, for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC) which has progressed after at least on...

Not yet enrolling
Advanced Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: AGEN1423

Phase 2

Bruno Bockorny

Boston, Massachusetts, United States

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Worcester, Massachusetts, United States of America and 89 other locations

Multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of anamorelin HCl. Approximately 100 subjects wit...

Enrolling
Metastatic Pancreatic Cancer
Drug: Placebo
Drug: Anamorelin Hydrochloride

Phase 2

Lahey Health
Lahey Health

Burlington, Massachusetts, United States

This study is being done to test the safety and effectiveness of combining ZN-c3 and Gemcitabine in participants with pancreatic cancer...

Enrolling
Pancreatic Ductal Adenocarcinoma
Advanced Pancreatic Adenocarcinoma
Drug: Gemzar
Drug: Zentalis

Phase 2

Brandon Huffman

Boston, Massachusetts, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems